Larvol Delta - Durable-benefits-but-no-improvements-in-overall-survival-what-can-we-learn-from-CheckMate-238-after-9-years-of-followup

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

http://www.ncbi.nlm.nih.gov/pubmed/42724840

Anna Spreafico; Carlos Diego Holanda Lopes; Daniel V Araujo

Sep 12, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next